Alaunos Therapeutics (TCRT) Capital Leases (2019 - 2023)
Alaunos Therapeutics' (TCRT) quarterly Capital Leases came in at $864000.0 in Q3 2023, down 62.98% YoY from $2.3 million in Q3 2022, and down 29.47% on a QoQ basis from $1.2 million in Q2 2023.
Alaunos Therapeutics (TCRT) Capital Leases (2019 - 2023) Analysis & Trends
Alaunos Therapeutics (TCRT) has 5 years of Capital Leases data on file, last reported at $864000.0 in Q3 2023.
- Quarterly Capital Leases fell 62.98% year-over-year to $864000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $864000.0 (down 62.98% YoY) and the FY2022 annual result came in at $2.2 million, down 51.57% from the prior year.
- Capital Leases fell to $864000.0 in Q3 2023, from $1.2 million in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $4.5 million in Q4 2021 to a low of $647000.0 in Q3 2019.
- A 5-year average of $2.0 million and a median of $1.6 million in 2019 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2020 — Capital Leases surged 155.8% — and 2023, when it plunged 62.98%.
- Tracing TCRT's Capital Leases over 5 years: stood at $1.6 million in 2019, then surged by 153.17% to $4.0 million in 2020, then rose by 13.09% to $4.5 million in 2021, then plunged by 51.57% to $2.2 million in 2022, then plunged by 60.51% to $864000.0 in 2023.
- The last three Capital Leases figures came in at $864000.0 (Q3 2023), $1.2 million (Q2 2023), and $2.0 million (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 864,000.00 |
| Jun 30, 2023 | 1.23 Mn |
| Mar 31, 2023 | 2.04 Mn |
| Dec 31, 2022 | 2.19 Mn |
| Sep 30, 2022 | 2.33 Mn |
| Jun 30, 2022 | 2.48 Mn |
| Mar 31, 2022 | 4.31 Mn |
| Dec 31, 2021 | 4.52 Mn |
| Dec 31, 2020 | 4.00 Mn |
| Sep 30, 2020 | 1.66 Mn |
| Jun 30, 2020 | 1.15 Mn |
| Mar 31, 2020 | 1.36 Mn |
| Dec 31, 2019 | 1.58 Mn |
| Sep 30, 2019 | 647,000.00 |
| Jun 30, 2019 | 778,000.00 |
| Mar 31, 2019 | 948,000.00 |